Unknown

Dataset Information

0

Application of an agr-Specific Antivirulence Compound as Therapy for Staphylococcus aureus-Induced Inflammatory Skin Disease.


ABSTRACT: Atopic dermatitis (AD) is a chronic inflammatory skin disease where more than 90% of patients affected are colonized with Staphylococcus aureus. In AD, S. aureus ?-toxin is a major virulence factor causing cutaneous inflammation via mast cell degranulation. ?-toxin is controlled by the S. aureus agr quorum sensing system, and thus we addressed whether interference with agr signaling would limit skin inflammation. Indeed, treatment of S. aureus with the agr-inhibitor solonamide B (SolB) abolished ?-toxin production and reduced skin inflammation in a mouse model of inflammatory skin disease, demonstrating the potential of antivirulence therapy in treating S. aureus-induced skin disorders.

SUBMITTER: Baldry M 

PROVIDER: S-EPMC6093339 | BioStudies | 2018-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC7106486 | BioStudies
1000-01-01 | S-EPMC5824847 | BioStudies
2002-01-01 | S-EPMC127674 | BioStudies
2014-01-01 | S-EPMC4055767 | BioStudies
1000-01-01 | S-EPMC6057012 | BioStudies
2020-01-01 | S-EPMC7339952 | BioStudies
2019-01-01 | S-EPMC6437270 | BioStudies
2010-05-14 | E-GEOD-10165 | ArrayExpress
2018-01-01 | S-EPMC5962727 | BioStudies
1998-01-01 | S-EPMC107643 | BioStudies